Literature DB >> 16201928

Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital.

Cécile Aubron1, Laurent Poirel, Nicolas Fortineau, Pierre Nicolas, Louis Collet, Patrice Nordmann.   

Abstract

Dissemination of metallo-beta-lactamases (carbapenemases) was investigated retrospectively among ceftazidimeand imipenem-resistant Pseudomonas aeruginosa isolates in a hematology unit in Marseilles, France, from September, 1995, to March, 1999. Sixteen clinical isolates and 23 environmental strains were identified, with a same bla (VIM-2) gene that encoded a carbapenemase identified in Southern Europe and South Korea. Five different genotypes were identified among clinical and environmental P. aeruginosa isolates all harboring an approximately 45-kb plasmid with bla (VIM-2)-positive class 1 integrons varying in structures. This study identified a hidden reservoir of carbapenemase producers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201928     DOI: 10.1089/mdr.2005.11.254

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  Class II transposon-borne structure harboring metallo-beta-lactamase gene blaVIM-2 in Pseudomonas putida.

Authors:  Laurent Poirel; Ludovic Cabanne; Louis Collet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.

Authors:  Laurent Poirel; Jean-Denis Docquier; Filomena De Luca; Annemie Verlinde; Louis Ide; Gian Maria Rossolini; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

3.  Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals.

Authors:  Yun-Song Yu; Ting-Ting Qu; Jian-Ying Zhou; Jie Wang; Hong-Yang Li; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

Review 4.  Management of febrile neutropenia in the era of bacterial resistance.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Ther Adv Infect Dis       Date:  2013-02

5.  Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.

Authors:  L Vettoretti; N Floret; D Hocquet; B Dehecq; P Plésiat; D Talon; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-07       Impact factor: 3.267

Review 6.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

Review 7.  Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

8.  Lauryl-poly-L-lysine: A New Antimicrobial Agent?

Authors:  Laetitia Vidal; Véronique Thuault; Arturo Mangas; Rafael Coveñas; Anne Thienpont; Michel Geffard
Journal:  J Amino Acids       Date:  2014-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.